Assessing Diaphragm Muscle Inactivity in Mechanically Ventilated ICU Patients (DIVIP)

April 11, 2018 updated by: Unity Health Toronto

Background: Mechanical ventilation is a life saving intervention in patients with acute respiratory failure, for instance, due to infection or trauma. The main goals of mechanical ventilation are to improve oxygenation and decrease the load imposed on the respiratory muscles. Unfortunately, mechanical ventilation comes with adverse events including disuse atrophy and weakness of the respiratory muscles. The diaphragm is the main muscle for inspiration and therefore this clinical entity is commonly referred to as ventilator-induced diaphragm dysfunction (VIDD). Several studies have shown that inspiratory muscle weakness is associated with adverse outcomes, including prolonged duration of mechanical ventilation. Inactivity or disuse is a recognized risk factor for the development of VIDD: disuse may result from excessive unloading of the diaphragm by the ventilator. Therefore, clinicians aim to limit the risk of VIDD by using ventilator modes that allow patients to perform at least part of the total work of breathing when deemed clinically appropriate. However, even when these so-called assisted modes for ventilation are used, excessive unloading of the diaphragm may occur; without using technology that allows monitoring of diaphragm function, the clinician is often uncertain as to whether this muscle is indeed actively working. Continuous recording of the electrical activity of the diaphragm (EAdi) is used to monitor diaphragm muscle activity in ICU patients. Furthermore, sonographic measurements of diaphragm thickness allows for an easy quantification of diaphragmatic activity (thickening fraction) as well as providing a potentially useful mechanism for studying diaphragm injury and function during mechanical ventilation.

Aim: To assess the duration of diaphragm muscle inactivity in patients admitted to the ICU using EAdi monitoring and to assess the correlation between diaphragm thicknening fraction, as measured by ultrasound, and electrical activity, as measured by EAdi.

Hypothesis: Diaphragm muscle inactivity frequently occurs in the early phase of ICU admission Design: Observational pilot study in ventilated adult ICU patients admitted to the ICU at St Michael's Hospital. The investigators aim to enroll 75 patients.

Primary outcome: Time from catheter positioning to first EAdi (> 5 uV last at least 5 minutes)

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

75

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5B 1W8
        • St. Michael's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients admitted to the ICU in whom the attending clinician has decided to insert the dedicated feeding tube (EAdi catheter) in the ICU or < 12 hours before admission

Description

Inclusion Criteria:

  • Patient admitted to the ICU
  • Intubation in the ICU or < 12 hours before admission
  • Expected duration of mechanical ventilation > 48 h
  • Edi monitoring tube / catheter in situ by the clinical team

Non-inclusion Criteria:

  • Anticipated removal of EAdi tube within 48 hours of ICU admission (e.g., for MRI, for endoscopic intervention)
  • High risk for intracranial hypertension or proven intracranial hypertension due to severe neurotrauma or substantial intracranial hemorrhage because these patients will likely need Magnetic Resonance Imaging. This can be discussed on a case-by-case basis based on the severity and initial findings
  • Lack of Servo-i NAVA capable ventilator, lack of EAdi catheter

Exclusion Criteria:

  • Phrenic nerve lesions (past medical history)
  • Contraindications to the insertion of a naso- or oro-gastric (feeding) tube
  • Patients already intubated for > 12 hours

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time from catheter positioning to first EAdi signal
Time Frame: Up to 5 days
> 5uV lasting at least 5 minutes
Up to 5 days

Secondary Outcome Measures

Outcome Measure
Time Frame
Time from endotracheal intubation to first EAdi signal
Time Frame: Up to 5 days
Up to 5 days
Time from catheter positioning until 24 hours of continuous EAdi signal
Time Frame: Up to 5 days
Up to 5 days
Number of patients without EAdi signal in the first 72 hours after intubation
Time Frame: Up to 3 days
Up to 3 days
Patient-ventilator interaction assessed by EAdi
Time Frame: Up to 5 days
Up to 5 days
Clinical characteristics associated with diaphragm inactivity
Time Frame: Up to 5 days
Up to 5 days
Correlation between diaphragm muscle thickness and diaphragm thickening fraction
Time Frame: Up to 5 days
Up to 5 days

Other Outcome Measures

Outcome Measure
Time Frame
Correlation between the electrical activity of the diaphragm and diaphragm and intercostal thickening fraction
Time Frame: Up to 5 days
Up to 5 days
Correlation between thickening fraction of the intercostal muscles and of the diaphragm
Time Frame: Up to 5 days
Up to 5 days
Changes in diaphragm and intercostal muscle thickness over time
Time Frame: Up to 5 days
Up to 5 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Laurent J. Brochard, MD, Unity Health Toronto

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2015

Primary Completion (Actual)

December 1, 2017

Study Completion (Actual)

December 1, 2017

Study Registration Dates

First Submitted

April 27, 2015

First Submitted That Met QC Criteria

April 29, 2015

First Posted (Estimate)

May 5, 2015

Study Record Updates

Last Update Posted (Actual)

April 12, 2018

Last Update Submitted That Met QC Criteria

April 11, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • REB #15-073

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Insufficiency

Subscribe